Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD (SZSE: 300534)
Health Care · Pharmaceuticals · CN
CN¥12.52
-0.48% today · +27.5% 1Y
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD (SZSE: 300534) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $567.01M and employs 641 people.
Over the last twelve months the share price has gained 27.5%, trading between 6.78 and 20.96.
Tweenvest scores Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD across four factors: quality 67/100, value 46/100, growth 64/100, dividend 10/100. Its strongest factor is quality.
300534 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $567.01M
- Revenue (TTM)
- $108.63M
- P/E
- 109.91
- EPS
- 0.11
- Dividend yield
- 0.32%
- Beta (5Y)
- 0.21
- 52-week high
- CN¥20.96
- 52-week low
- CN¥6.78
- Avg volume (3M)
- —
- Shares outstanding
- 303.35M
- Employees
- 641
- Next earnings
- —
About Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD
Gansu Longshenrongfa Pharmaceutical Industry Co.,Ltd operates as a pharmaceutical enterprise, focusing on the research, development, manufacturing, and commercialization of traditional Chinese medicines, health supplements, and active pharmaceutical ingredients (APIs). Its extensive product line includes therapeutic remedies such as Yuanhu Analgesic dropping pills, Qiwei Wenyang capsules, Maxing cough capsules, Shuxinning tablets, Panax notoginseng pills, Anti-inflammatory and gallbladder tablets, Children's Qingfei cough tablets, Pediatric Qinggan tablets, Suanzaoren oil dropping pills, Xiaoshuan Tongluo tablets, Xiaoyanlidan tablets, Compound Danshen tablets, Astragalus Angelica capsules, and berberine tannin films. Beyond its core manufacturing, the company is actively involved in the cultivation, procurement, processing, and distribution of Chinese medicinal raw materials. Its operations further encompass project investment and management, alongside the import, sale, logistics, and export of pharmaceutical goods. Established in 2002, Gansu Longshenrongfa Pharmaceutical Industry Co.,Ltd is headquartered in Lanzhou, China.
- ISIN
- CNE100002CP5
- Founded
- 2002
- Listed since
- Sep 13, 2016
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Zhejiang Yatai Pharmaceutical Co., Ltd.SZSE: 002370 | $580.00M | CN¥5.21 | +0.97% |
| Phathom Pharmaceuticals, Inc.NasdaqGS: PHAT | $575.87M | $7.08 | -2.41% |
| CorMedix Inc.NasdaqGM: CRMD | $575.23M | $7.59 | +2.78% |
| Zhejiang Starry Pharmaceutical Co.,Ltd.SHSE: 603520 | $570.75M | CN¥8.72 | -0.34% |
| Aclaris Therapeutics, Inc.NasdaqGS: ACRS | $563.77M | $3.70 | -3.39% |
| FDC LimitedBSE: 531599 | $555.31M | Rs330.10 | -1.62% |
| Xuanzhu Biopharmaceutical Co., Ltd.SEHK: 2575 | $552.76M | HK$8.38 | -4.56% |
| Kingchem (Liaoning) Life Science Co., Ltd.SZSE: 301509 | $545.04M | CN¥30.31 | -3.01% |
Figures last refreshed Oct 11, 2026.